Yuxin Sun, Cong Li, Hang Yin, Kunyan Li, Ying Wang, Shuailong Zhang, Yi Zhao, Jing Wang, Weifeng Mao
{"title":"小檗碱通过DNA连接酶III的衰减使乳腺癌细胞对辐射敏感","authors":"Yuxin Sun, Cong Li, Hang Yin, Kunyan Li, Ying Wang, Shuailong Zhang, Yi Zhao, Jing Wang, Weifeng Mao","doi":"10.1111/jcmm.70836","DOIUrl":null,"url":null,"abstract":"<p>Berberine (BBR) is an isoquinoline alkaloid with a variety of biological activities, including anti-microbial and anti-tumoral activities. However, the cellular targets of BBR and the roles of BBR in the radiosensitivity of breast cancer cells are not well defined. In this study, we investigated the effects of BBR on the radiosensitivity of BT549 triple-negative breast cancer cells. Through RNA-seq results, we found that BBR significantly down-regulated the expression of DNA ligases. The results of western blot and comet assay confirmed that BBR attenuated DNA ligase III (LIGIII) expression and caused DNA damage in a dose-dependent manner. The results of electron microscopy showed that BBR decreased mitochondrial copies and induced mitochondrial autophagy. Clonal formation analysis showed that BBR sensitised breast cancer cells to irradiation. The genetic complementation and interference assays showed that the effect of BBR on the radiosensitivity of BT549 breast cancer cells is dependent on the expression of LIGIII. These results contribute to the understanding of the effects of BBR on cellular DNA repair and the clinical application of BBR in breast cancer therapy.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 17","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70836","citationCount":"0","resultStr":"{\"title\":\"Berberine Sensitises Breast Cancer Cells to Radiation via the Attenuation of DNA Ligase III\",\"authors\":\"Yuxin Sun, Cong Li, Hang Yin, Kunyan Li, Ying Wang, Shuailong Zhang, Yi Zhao, Jing Wang, Weifeng Mao\",\"doi\":\"10.1111/jcmm.70836\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Berberine (BBR) is an isoquinoline alkaloid with a variety of biological activities, including anti-microbial and anti-tumoral activities. However, the cellular targets of BBR and the roles of BBR in the radiosensitivity of breast cancer cells are not well defined. In this study, we investigated the effects of BBR on the radiosensitivity of BT549 triple-negative breast cancer cells. Through RNA-seq results, we found that BBR significantly down-regulated the expression of DNA ligases. The results of western blot and comet assay confirmed that BBR attenuated DNA ligase III (LIGIII) expression and caused DNA damage in a dose-dependent manner. The results of electron microscopy showed that BBR decreased mitochondrial copies and induced mitochondrial autophagy. Clonal formation analysis showed that BBR sensitised breast cancer cells to irradiation. The genetic complementation and interference assays showed that the effect of BBR on the radiosensitivity of BT549 breast cancer cells is dependent on the expression of LIGIII. These results contribute to the understanding of the effects of BBR on cellular DNA repair and the clinical application of BBR in breast cancer therapy.</p>\",\"PeriodicalId\":101321,\"journal\":{\"name\":\"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE\",\"volume\":\"29 17\",\"pages\":\"\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-09-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70836\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jcmm.70836\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jcmm.70836","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Berberine Sensitises Breast Cancer Cells to Radiation via the Attenuation of DNA Ligase III
Berberine (BBR) is an isoquinoline alkaloid with a variety of biological activities, including anti-microbial and anti-tumoral activities. However, the cellular targets of BBR and the roles of BBR in the radiosensitivity of breast cancer cells are not well defined. In this study, we investigated the effects of BBR on the radiosensitivity of BT549 triple-negative breast cancer cells. Through RNA-seq results, we found that BBR significantly down-regulated the expression of DNA ligases. The results of western blot and comet assay confirmed that BBR attenuated DNA ligase III (LIGIII) expression and caused DNA damage in a dose-dependent manner. The results of electron microscopy showed that BBR decreased mitochondrial copies and induced mitochondrial autophagy. Clonal formation analysis showed that BBR sensitised breast cancer cells to irradiation. The genetic complementation and interference assays showed that the effect of BBR on the radiosensitivity of BT549 breast cancer cells is dependent on the expression of LIGIII. These results contribute to the understanding of the effects of BBR on cellular DNA repair and the clinical application of BBR in breast cancer therapy.
期刊介绍：
The Journal of Cellular and Molecular Medicine serves as a bridge between physiology and cellular medicine, as well as molecular biology and molecular therapeutics. With a 20-year history, the journal adopts an interdisciplinary approach to showcase innovative discoveries.
It publishes research aimed at advancing the collective understanding of the cellular and molecular mechanisms underlying diseases. The journal emphasizes translational studies that translate this knowledge into therapeutic strategies. Being fully open access, the journal is accessible to all readers.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
